Chlorophyllin is a water soluble derivative of chlorophyll. It has chemopreventive properties and forms a non-covalent complex with many mutagenic/carcinogenic molecules. Chlorophyllin inhibits cancer initiation and progression by targeting multiple molecules and pathways involved in the metabolism of carcinogens, cell cycle progression, apoptosis evasion, invasion, and angiogenesis. The modulatory effects of Chlorophyllin to be mediated via abrogation of key oncogenic signal transduction pathways such as nuclear factor kappa B, Wnt/β-catenin, and phosphatidylinositol-3-kinase/Akt signaling. Chlorophyllin sodium copper salt mitigates radiation-induced hematopoietic syndrome by increasing the abundance of hematopoietic stem cells, enhancing granulopoiesis, and stimulating prosurvival pathways in bone marrow cells and lymphocytes. In addition, chlorophyllin exhibits antioxidant, antiapoptotic and immunostimulatory effects. Chlorophyllin is intended to improve the quality of life in people who have fecal incontinence due to spinal cord injury, bowel cancer, psychotic disorder, terminal illness, or other disorders. Chlorophyllin is also used by people who have had a colostomy or ileostomy
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0030097 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25872101 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Palliative | Derifil Approved UseDerifil has been used in alternative medicine as an aid to reduce the odor of urine or feces (bowel movements).
Derifil is intended to improve the quality of life in people who have fecal incontinence due to spinal cord injury, bowel cancer, psychotic disorder, terminal illness, or other disorders. This medicine is also used by people who have had a colostomy or ileostomy. |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6628224
urinary odor: each patient received chlorophyllin 100 mg/d for two weeks and placebo daily for two weeks, separated by a washout period of one week.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27098305
It was investigated the effects on cell proliferation and the expression of genes involved in apoptosis, and the cell cycle in HB4a cells treated with Chlorophyllin (Chl). Chl was cytotoxic and induced apoptosis to HB4a cells at 400 μg/mL. Analysis of gene expression showed that there was a decrease in the mRNA level of BIRC5 and CCNA2 genes involved in apoptosis and cell cycle progression, respectively. The proapoptotic gene BAX and the antiapoptotic genes BCL-2 and BCL-XL were upregulated. The cytotoxicity of Chl has been attributed to increases in the expression of BAX and decreases in the expression of genes involved in the cell cycle, but increases in the expression of anti-apoptotic genes suggests a mechanism for protection from cell death induced by Chl.
Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 19:00:04 GMT 2023
by
admin
on
Fri Dec 15 19:00:04 GMT 2023
|
Record UNII |
1D276TYV9O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1204 (Number of products:135)
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
20852
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
ALTERNATIVE | |||
|
SUB29019
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
11006-34-1
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
NON-SPECIFIC SUBSTITUTION | |||
|
CHEMBL2108920
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
1366841
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
1D276TYV9O
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
C166492
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
82242
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
ALTERNATIVE | |||
|
CHLOROPHYLLIN
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
SUB20654
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
1D276TYV9O
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY | |||
|
C007020
Created by
admin on Fri Dec 15 19:00:04 GMT 2023 , Edited by admin on Fri Dec 15 19:00:04 GMT 2023
|
PRIMARY |
All of the following components must be present:
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|